Acute Hepatitis

Etiology and Risk Factors

Etiology / mechanism	Clinical clues	Diagnostic direction
Hepatitis A; often food/water or close-contact exposure	Acute self-limited infection, constitutional symptoms and possible jaundice; does not cause chronic hepatitis.	IgM anti-HAV in a compatible illness; assess travel, food, outbreak, vaccination and exposure.
Hepatitis B; blood, sexual or perinatal exposure	Can cause acute illness, immune-mediated hepatocyte injury, and, in some patients, chronic infection.	HBsAg and IgM anti-HBc help assess acute infection; HBV DNA and other serologies when indicated. Interpretation depends on the whole pattern.
Hepatitis C; blood exposure	Acute infection is often asymptomatic; antibody may not yet be detectable during early viremia.	HCV RNA testing when recent infection is suspected, alongside anti-HCV as appropriate.
Hepatitis D and E	HDV requires HBV; HEV is exposure-dependent and may be severe in some populations.	HDV testing in relevant HBV infection; HEV testing when epidemiology/clinical circumstances warrant.
Medication, supplement or toxin injury	Prescription/OTC agents, acetaminophen, herbal products, and variable latency; injury may be intrinsic or idiosyncratic.	Detailed medication timeline, acetaminophen level in compatible acute exposure, toxicology-specific assessment.
Hypoxic/ischemic or immune-mediated injury	Shock or impaired hepatic perfusion; alternatively autoimmune features without infectious explanation.	Assess hemodynamics, oxygen delivery, autoantibodies/IgG and other causes as clinically indicated.

Read viral markers as a pattern, not an isolated positive

IgM anti-HAV supports recent HAV infection in the appropriate setting. Acute HBV infection commonly has HBsAg plus IgM anti-HBc. IgM anti-HBc may also be positive during severe chronic HBV flares or reactivation, so interpret it with HBsAg, total anti-HBc, anti-HBs and, when indicated, HBV DNA. Acute HCV can have detectable RNA before anti-HCV seroconversion, so recent exposure with negative antibody may still require RNA testing. HDV evaluation is relevant only with HBV infection. HEV warrants exposure-sensitive consideration, particularly with compatible travel/food history, immunocompromise or pregnancy (Centers for Disease Control and Prevention, 2026; Mukhtar & Khalili, 2019; Williams & Gordon-Walker, 2023).

Epidemiology and Clinical Context

Population context: Hepatitis A is frequently asymptomatic in young children but more often symptomatic in adults. Pregnancy can increase the consequences of selected causes of acute liver injury. Perinatally acquired HBV is much more likely to become chronic than adult-acquired infection; assess acute severity through hepatic function and mental status rather than age or aminotransferase magnitude alone (Mukhtar & Khalili, 2019; Williams & Gordon-Walker, 2023).

Pathophysiology

Mechanism: hepatocyte injury is not the same as hepatic failure

Viral infection, immune activation, toxins, drug-related injury, and ischemia can disrupt hepatocyte membranes or trigger apoptosis. Intracellular aminotransferases enter the blood, producing an AST/ALT-predominant biochemical pattern. In contrast, impaired synthesis of coagulation factors prolongs the prothrombin time/international normalized ratio (INR); impaired bilirubin processing causes jaundice; and failure to detoxify and regulate cerebral metabolism can cause encephalopathy. Severe acute hepatic dysfunction may also produce hypoglycemia and renal injury (Mukhtar & Khalili, 2019).

Clinical Manifestations

Patients may experience fatigue, anorexia, nausea, right upper quadrant discomfort, fever, dark urine, pale stools, pruritus or jaundice. Physical examination can be normal. Laboratory patterns help organize the differential, but no single pattern establishes etiology. Concurrent biliary obstruction, hemolysis, metabolic disease and other causes of jaundice should be considered when findings do not fit uncomplicated hepatitis (Mukhtar & Khalili, 2019; Williams & Gordon-Walker, 2023).

Diagnostic Evaluation

• Determine time course and prior liver status. Take a complete exposure history: alcohol, prescriptions, acetaminophen-containing products, supplements, occupational toxins, travel, food, sexual and blood exposures, injections, pregnancy-related conditions when relevant, and recent hemodynamic insults (Williams & Gordon-Walker, 2023).
• Evaluate severity first: vital signs, hydration, orientation/attention, glucose, INR/PT, bilirubin, AST/ALT, alkaline phosphatase, albumin, CBC, renal function and electrolytes. Repeat testing when the trajectory is uncertain or dysfunction may evolve (Williams & Gordon-Walker, 2023).
• Order cause-directed viral serologies and nucleic acid tests, acetaminophen studies or toxicology assessment, autoimmune/metabolic studies, and hepatobiliary ultrasound when clinically appropriate. Distinguish a hepatocellular pattern from extrahepatic biliary obstruction (Williams & Gordon-Walker, 2023).

Expected Findings

Finding	Primary interpretation	Clinical caution
AST/ALT elevation	Hepatocellular injury, not necessarily failure of synthesis.	Magnitude alone cannot classify severity; very high values may follow ischemia or toxic injury.
ALP elevation out of proportion to AST/ALT	Cholestatic or infiltrative pattern.	Evaluate biliary obstruction and cholestatic drug injury; imaging may be required.
Elevated conjugated bilirubin / jaundice	Impaired bilirubin excretion or hepatobiliary flow.	Trend bilirubin and INR separately from aminotransferases; falling enzymes alone do not establish restored liver function.
Increasing INR, hypoglycemia or new altered mental status	Impaired synthetic/metabolic function and possible acute liver failure.	Urgent reassessment, monitored care, and transplant-center consultation when appropriate.
Rising creatinine, oliguria, hypotension or acidosis	Multiorgan injury, impaired perfusion or toxin-related harm.	Resuscitation and etiologic work-up must occur in parallel.

Differential Diagnosis

Time-sensitive differential diagnoses

Abrupt extreme aminotransferase elevation can reflect hypoxic hepatitis after hemodynamic compromise or toxic injury, not only viral disease. In pregnancy, acute liver abnormalities may also represent pregnancy-specific disorders such as HELLP syndrome or acute fatty liver of pregnancy; urgent obstetric assessment takes precedence over a routine hepatitis work-up. Acetaminophen toxicity requires timely toxicology involvement even if the exposure history is incomplete. Acute liver failure is a dynamic clinical syndrome requiring early transplant-center discussion, serial INR, glucose, renal and neurologic assessments, and airway/critical-care planning when encephalopathy evolves (Lee et al., 2011; Williams & Gordon-Walker, 2023).

Diagnostic Limitations and Reassessment

A very high ALT reflects substantial hepatocyte injury but does not, by itself, quantify liver reserve, predict fibrosis, or diagnose acute liver failure. A falling ALT can reflect improvement or loss of viable hepatocytes during deterioration; interpret the direction of bilirubin, INR, glucose, mental status, lactate, and clinical physiology together. Albumin is a slower marker of hepatic synthetic function and may remain normal early in an acute illness (Williams & Gordon-Walker, 2023).

Treatment and Management

• Treat immediately actionable causes and complications. Discontinue suspected hepatotoxic exposures; use N-acetylcysteine promptly for suspected acetaminophen toxicity according to current toxicology protocols. Support perfusion, glucose, electrolytes and nutrition. Antiviral, immune-directed, or other specific treatment requires a confirmed or strongly suspected diagnosis and current specialist guidance (Lee et al., 2011; Williams & Gordon-Walker, 2023).

Complications and Red Flags

Acute liver failure: a time-critical distinction

In a patient without established cirrhosis, newly developed hepatic encephalopathy together with INR of at least 1.5 during an illness of less than 26 weeks is the conventional acute liver failure framework. Acute-on-chronic liver failure is a different clinical syndrome. Acute liver failure can rapidly cause cerebral edema, infection, coagulopathy, hypoglycemia, acute kidney injury and circulatory collapse. New confusion or somnolence with rising INR requires emergency evaluation and early transplantation-center involvement; awaiting jaundice or a particular aminotransferase threshold is unsafe (Lee et al., 2011; Williams & Gordon-Walker, 2023).

Clinical Reasoning Priorities

Patient A develops nausea and jaundice with ALT 1,400 U/L, normal INR, normal glucose and intact attention. The findings show substantial injury but do not establish hepatic failure. Patient B has ALT 550 U/L, INR 2.1, hypoglycemia and new disorientation. Despite the lower ALT, Patient B has evidence of severe hepatic dysfunction and needs immediate escalation. The comparison illustrates why injury markers and functional markers must be evaluated separately (Williams & Gordon-Walker, 2023).

---

---

References

Centers for Disease Control and Prevention. (2026, August 14). Clinical testing and diagnosis for hepatitis B. https://www.cdc.gov/hepatitis-b/hcp/diagnosis-testing/index.html

Lee, W. M., Larson, A. M., & Stravitz, R. T. (2011). AASLD position paper: The management of acute liver failure: Update 2011. American Association for the Study of Liver Diseases. https://www.aasld.org/sites/default/files/2023-03/Acute%20Liver%20Failure%20Update2011.pdf

Mukhtar, N. A., & Khalili, M. (2019). Liver disease. In G. D. Hammer & S. J. McPhee (Eds.), Pathophysiology of disease: An introduction to clinical medicine (8th ed., Chapter 14). McGraw-Hill Education.

Williams, M. J., & Gordon-Walker, T. T. (2023). Hepatology. In I. D. Penman, S. H. Ralston, M. W. J. Strachan, & R. P. Hobson (Eds.), Davidson’s principles and practice of medicine (24th ed., pp. 859–920). Elsevier.